Publication:
The effect of antiproteinuric treatment on lipid levels in patients with focal segmental glomerulosclerosis and membranous glomerulopathy

Simple item page
dc.contributor.authorGürsu, MELTEM
dc.contributor.authorOZTURK, Savaş
dc.contributor.authorKÜÇÜK, Hatice
dc.contributor.authorAydın, Zeki
dc.contributor.authorşar, Fuat
dc.contributor.authorYAZICI, Halil
dc.contributor.authorKUCUK, Mehmet
dc.contributor.authorOZKAN, Oktay
dc.contributor.authorTÜRKMEN, Aydin
dc.contributor.authorKazancioǧlu, RÜMEYZA
dc.contributor.institutionauthorGÜRSU, MELTEM
dc.contributor.institutionauthorKAZANCIOĞLU, RÜMEYZA
dc.date.accessioned2019-10-05T14:27:21Z
dc.date.available2019-10-05T14:27:21Z
dc.date.issued2013-02-15
dc.identifier
dc.identifier.citationGürsu M., OZTURK S., KÜÇÜK H., Aydın Z., şar F., YAZICI H., KUCUK M., OZKAN O., TÜRKMEN A., Kazancioǧlu R., -The effect of antiproteinuric treatment on lipid levels in patients with focal segmental glomerulosclerosis and membranous glomerulopathy-, Turkish Nephrology, Dialysis and Transplantation Journal, cilt.22, ss.72-77, 2013
dc.identifier.doi10.5262/tndt.2013.1001.10
dc.identifier.scopus84873589437
dc.identifier.trdizinISSN: 1300-7718
dc.identifier.urihttps://hdl.handle.net/20.500.12645/3934
dc.language.isoen
dc.titleThe effect of antiproteinuric treatment on lipid levels in patients with focal segmental glomerulosclerosis and membranous glomerulopathy
dc.typeArticle
dspace.entity.typePublication
local.article.journalnameKlinik Psikofarmakoloji Bulteni
local.avesis.id5face044-b506-462e-a04d-8390719af0f5
local.avesis.response3804
local.publication.isinternational1
relation.isAuthorOfPublicationa6446eac-0ccd-4457-9227-3fc72dec68d1
relation.isAuthorOfPublicationeca7bd30-6b6e-444d-96ae-2961c39f2107
relation.isAuthorOfPublication.latestForDiscoverya6446eac-0ccd-4457-9227-3fc72dec68d1
Files
Collections
Yayınlar - Eserler
Tıp Fakültesi